M Frezza

2.6k total citations · 1 hit paper
33 papers, 1.9k citations indexed

About

M Frezza is a scholar working on Epidemiology, Oncology and Rheumatology. According to data from OpenAlex, M Frezza has authored 33 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in M Frezza's work include Liver Disease Diagnosis and Treatment (13 papers), Drug Transport and Resistance Mechanisms (7 papers) and Folate and B Vitamins Research (6 papers). M Frezza is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Drug Transport and Resistance Mechanisms (7 papers) and Folate and B Vitamins Research (6 papers). M Frezza collaborates with scholars based in Italy, United States and United Kingdom. M Frezza's co-authors include C. Di Padova, Gabriele Pozzato, Enrique Baraona, M. Terpin, Charles S. Lieber, Liliana Chemello, L. Chiesa, Pietro Casarin, A. Albertí and C. Surrenti and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

M Frezza

31 papers receiving 1.8k citations

Hit Papers

High Blood Alcohol Levels in Women 1990 2026 2002 2014 1990 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Frezza Italy 14 1.0k 765 500 218 202 33 1.9k
C. Di Padova Italy 19 875 0.9× 943 1.2× 238 0.5× 260 1.2× 243 1.2× 50 2.2k
David H. Van Thiel United States 25 634 0.6× 381 0.5× 577 1.2× 211 1.0× 112 0.6× 61 2.1k
Charles L. Mendenhall United States 24 1.7k 1.7× 1.4k 1.8× 1.0k 2.0× 506 2.3× 115 0.6× 52 2.9k
Theresa M. Worner United States 22 839 0.8× 1000 1.3× 289 0.6× 304 1.4× 45 0.2× 43 1.8k
James G. Rankin Australia 24 900 0.9× 664 0.9× 463 0.9× 161 0.7× 45 0.2× 52 1.6k
C L Mendenhall United States 18 1.1k 1.1× 830 1.1× 637 1.3× 274 1.3× 44 0.2× 40 1.6k
Daniel Rudman United States 24 480 0.5× 134 0.2× 576 1.2× 304 1.4× 282 1.4× 34 1.9k
Joan E. Blake Canada 22 1.2k 1.2× 847 1.1× 446 0.9× 253 1.2× 20 0.1× 30 1.7k
Simona Moscatiello Italy 19 1.1k 1.1× 232 0.3× 289 0.6× 857 3.9× 60 0.3× 29 1.9k
Yuko Ishizaka Japan 27 673 0.7× 274 0.4× 150 0.3× 549 2.5× 116 0.6× 68 2.5k

Countries citing papers authored by M Frezza

Since Specialization
Citations

This map shows the geographic impact of M Frezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Frezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Frezza more than expected).

Fields of papers citing papers by M Frezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Frezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Frezza. The network helps show where M Frezza may publish in the future.

Co-authorship network of co-authors of M Frezza

This figure shows the co-authorship network connecting the top 25 collaborators of M Frezza. A scholar is included among the top collaborators of M Frezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Frezza. M Frezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Morra, Aldo, et al.. (1998). [Complete remission of hepatocarcinoma metastasis during palliative treatment with tamoxifen].. PubMed. 96(3). 263–5. 2 indexed citations
3.
Frezza, M. (1998). [Apropos of primary sarcomas of the uterus with illustration of a case of sarcoma of the portio].. PubMed. 55. 45–52.
4.
Chemello, Liliana, Paola Bonetti, Luisa Cavalletto, et al.. (1995). Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology. 22(3). 700–706. 157 indexed citations
5.
Chemello, Liliana, Luisa Cavalletto, Franco Noventa, et al.. (1995). Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon‐α. Journal of Viral Hepatitis. 2(2). 91–96. 53 indexed citations
6.
Albertí, A., Liliana Chemello, Paola Bonetti, et al.. (1993). Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. Journal of Hepatology. 17. S123–S126. 64 indexed citations
7.
Chemello, Liliana, D. Cavalletto, Patrizia Pontisso, et al.. (1993). Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease. Hepatology. 17(2). 179–182. 47 indexed citations
8.
Frezza, M & M. Terpin. (1992). The Use of S-Adenosyl-L-Methionine in the Treatment of Cholestatic Disorders. Clinical Drug Investigation. 4(S4). 101–108. 9 indexed citations
9.
Frezza, M, C. Di Padova, Gabriele Pozzato, et al.. (1990). High Blood Alcohol Levels in Women. New England Journal of Medicine. 322(2). 95–99. 984 indexed citations breakdown →
10.
Caballería, Joan, M Frezza, Rolando Hernández‐Muñoz, et al.. (1989). Gastric origin of the first-pass metabolism of ethanol in humans: Effect of gastrectomy. Gastroenterology. 97(5). 1205–1209. 124 indexed citations
11.
Frezza, M, et al.. (1989). Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation.. PubMed. 34(1-2). 22–8. 8 indexed citations
12.
Frezza, M, R Tritapepe, Gabriele Pozzato, & C. Di Padova. (1988). Prevention of S-adenosylmethionine of estrogen-induced hepatobiliary toxicity in susceptible women.. PubMed. 83(10). 1098–102. 20 indexed citations
13.
Frezza, M, et al.. (1986). Alteration in Sulfobromphthalein Hepatic Storage Capacity (S) in Non‐Pregnant Women Previously Affected with Intrahepatic Cholestasis of Pregnancy (Icp). Acta Obstetricia Et Gynecologica Scandinavica. 65(6). 577–580. 3 indexed citations
14.
Frezza, M, et al.. (1985). Gallbladder volume and contraction in non-pregnant women previously affected with intrahepatic cholestasis of pregnancy.. 17(6). 311–313. 1 indexed citations
15.
Toigo, G., et al.. (1984). [Short-term treatment of chronic recurrent hepatic encephalopathy with enteral administration of a mixture rich in branched-chain amino acids and energy].. PubMed. 65(2). 79–85. 2 indexed citations
16.
Frezza, M, Gabriele Pozzato, L. Chiesa, Giorgio Stramentinoli, & C. Di Padova. (1984). Reversal of Intrahepatic Cholestasis of Pregnancy in Women after High Dose S-Adenosyl-L-Methionine Administration†. Hepatology. 4(2). 274–278. 114 indexed citations
17.
Cobelli, Claudio, M Frezza, & Claudio Tiribelli. (1975). Modeling, identification and parameter estimation of bilirubin kinetics in normal, hemolytic and Gilbert's states. Computers and Biomedical Research. 8(6). 522–537. 18 indexed citations
18.
Frezza, M, Claudio Tiribelli, E. Panfili, & Gabriella Sandri. (1974). Evidence for the existence of a carrier for bromosulphonphthalein in the liver cell plasma membrane. FEBS Letters. 38(2). 125–128. 18 indexed citations
19.
Frezza, M, et al.. (1973). Bilirubin 3H kinetic studies: pattern of normal,Gilbert's syndrome amd haemolitic patients. 20. 363–371. 3 indexed citations
20.
Frezza, M, et al.. (1966). [Familial brain disease with presence of a small metacentric extra chromosome].. PubMed. 15(3). 107–14. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026